Brussels, 05/01/2012 (Agence Europe) - On Thursday 5 January, European Ombudsman Nikiforos Diamandouros hailed the fact that the European Medicines Agency (EMA) had released adverse reaction reports related to Septrin, a medicine for the treatment of bacterial infections. This followed a complaint from a law firm, whose request for access to the reports had been refused for reasons pertaining to the protection of commercial interests. Further to an inquiry, the Ombudsman said that EMA should...